About Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP
Clinical Trials at Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP
During the past decade, Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP"
#1 collaborator was "Coordenação de Aperfeiçoamento de Pessoal de Nível Superior." with 1 trials as a collaborator, "Fundação de Amparo à Pesquisa do Estado de São Paulo" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP
According to Clinical.Site data, the most researched conditions in "Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP" are
"Acute Coronary Syndrome" (1 trials), "COVID-19" (1 trials), "Colitis, Ulcerative" (1 trials), "Crohn's Disease" (1 trials) and "Laparoscopic Cholecystectomy" (1 trials). Many other conditions were trialed in "Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP" in a lesser frequency.
Clinical Trials Intervention Types at Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP
Most popular intervention types in "Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Antiplatelet Monotherapy" (1 trials), "Baricitinib" (1 trials), "LY3471851" (1 trials) and "Mirikizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP
The vast majority of trials in "Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP" are
5 trials for "All" genders.
Clinical Trials Status at Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP
Currently, there are NaN active trials in "Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".